Genoil Inc. Files 6-K for Period Ending June 30, 2025
Ticker: GNOLF · Form: 6-K · Filed: Aug 14, 2025 · CIK: 1261002
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Genoil Inc. (GNOLF) filed its 6-K for Q2 2025, showing standard reporting. No major news.
AI Summary
Genoil Inc. filed a Form 6-K for the period ending June 30, 2025. The company, incorporated in New York, operates in the Oil, Gas Field Services sector. Its principal executive offices are located at One Rockefeller Plaza, 11th Floor, New York, NY 10020.
Why It Matters
This filing provides an update on Genoil Inc.'s operational and financial status as of mid-2025, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that provides standard company information and does not appear to contain significant new developments or risks.
Key Players & Entities
- GENOIL INC (company) — Registrant
- June 30, 2025 (date) — Period ending date
- One Rockefeller Plaza, 11th Floor, New York, NY 10020 (address) — Principal executive office
- 1934 Act (legal_act) — SEC Act
FAQ
What is the filing type and reporting period for Genoil Inc.?
The filing is a Form 6-K, reporting for the period ending June 30, 2025.
Where are Genoil Inc.'s principal executive offices located?
Genoil Inc.'s principal executive offices are located at One Rockefeller Plaza, 11th Floor, New York, NY 10020.
Under which SEC Act is this Form 6-K filed?
This Form 6-K is filed under the 1934 Act.
Does Genoil Inc. file annual reports under Form 20-F or 40-F?
Genoil Inc. indicates it files annual reports under Form 20-F.
What is the Standard Industrial Classification for Genoil Inc.?
The Standard Industrial Classification for Genoil Inc. is OIL, GAS FIELD SERVICES, NBC [1389].
Filing Stats: 244 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2025-08-14 15:17:49
Filing Documents
- gnolf_6k.htm (6-K) — 11KB
- gnolf_ex991.htm (EX-99.1) — 310KB
- 0001654954-25-009634.txt ( ) — 323KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Genoil Inc. (Registrant) Date: August 14, 2025 By: /s/ David Lifschultz Name: David Lifschultz Title: CEO 3